Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions
Clinical trial NCT04211103 · UNKNOWN
Trial details
- NCT number
- NCT04211103
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2024-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.